EOG
32
3
FOXA
69
5
KMB
31
3
MSI
57
3
NOV
50
3
ICE
55
2
CVX
17
3
ALLE
25
4
AZO
50
2
GT
47
4
KEY
27
3
MKC
53
2
RIG
35
6
CPB
27
5
MAT
43
2
TGT
47
3
CRM
67
2
AON
30
2
HPE
38
2
SPG
50
4
EOG
32
3
FOXA
69
5
KMB
31
3
MSI
57
3
NOV
50
3
ICE
55
2
CVX
17
3
ALLE
25
4
AZO
50
2
GT
47
4
KEY
27
3
MKC
53
2
RIG
35
6
CPB
27
5
MAT
43
2
TGT
47
3
CRM
67
2
AON
30
2
HPE
38
2
SPG
50
4
Financhill
Back

Arrowhead Pharmaceuticals 10K Form

Sell
17

ARWR
Arrowhead Pharmaceuticals

Last Price:
$19.56
Seasonality Move:
23.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARWR News And Ratings

See the #1 stock for the next 7 days that we like better than ARWR

ARWR Financial Statistics

Sales & Book Value

Annual Sales: $3.6M
Cash Flow: $-161.5M
Price / Cash Flow: 0
Annual Sales: $1.49
Price / Book: 13.17

Profitability

EPS (TTM): -5.01000
Net Income (TTM): $-599.5M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Arrowhead Pharmaceuticals Earnings Forecast

Key Arrowhead Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 20 years for ARWR is 0.00%.
  • The Selling, General & Administrative Expenses for ARWR have been equal to 2,726.56% of Gross Profit Margin.
  • The Research & Development expenses have been 14,245.85% of Revenue.
  • The Interest Expense is -5.40% of Operating Income.
  • The Net Earning history of ARWR is -16,882.37% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 12 years.

Arrowhead Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARWR
CUSIP: 04280A
Website: arrowheadpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARWR Technical Analysis vs Fundamental Analysis

Sell
17
Arrowhead Pharmaceuticals (ARWR) is a Sell

Is Arrowhead Pharmaceuticals a Buy or a Sell?